Argent Biopharma (AU:RGT) has released an update.
Argent Biopharma Limited has announced the quotation of 666,667 fully paid ordinary shares on the Australian Securities Exchange, following a previously disclosed transaction. This move is likely to attract attention from investors tracking developments in the biotech sector, as the company expands its market presence.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
